Actively Recruiting
Evaluating Innovative Technologies and Approaches to Addressing Cervical Cancer in Gaza and Maputo Cidade Provinces in Mozambique
Led by M.D. Anderson Cancer Center · Updated on 2025-11-04
14600
Participants Needed
1
Research Sites
319 weeks
Total Duration
On this page
Sponsors
M
M.D. Anderson Cancer Center
Lead Sponsor
P
Population Services International
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this operational research study is to develop, implement and test integrated CCS\&PT and voluntary FP service delivery models to evaluate whether integrated service delivery can optimize uptake and health impact of both services. The study objectives and learning questions are listed below, along with key outcomes that will be measured.
CONDITIONS
Official Title
Evaluating Innovative Technologies and Approaches to Addressing Cervical Cancer in Gaza and Maputo Cidade Provinces in Mozambique
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Women aged 30 to 49 years or all women living with HIV
- Not currently pregnant
- Have a cervix (no total hysterectomy removing the cervix)
- Living in Maputo or Gaza provinces
- Willing and able to provide informed consent for services
You will not qualify if you...
- Not meeting the inclusion criteria
- Physical or mental impairment that prevents participation
- Currently pregnant
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
M D Anderson Cancer Center
Houston, Texas, United States, 77030
Actively Recruiting
Research Team
M
Mila Salecedo, MD, PHD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
SCREENING
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here